Patients with type 2 diabetes who have poor blood glucose control are enrolled to evaluate the efficacy and safety of the HbA1c prediction model for adjust the hypoglycemic treatment regimen, compared with the conventional treatment using self-monitoring blood glucose or glycated albumin.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
150
HbA1c prediction model was developed based on fasting capillary blood glucose and postprandial capillary blood glucose from self-monitoring blood glucose. Since HbA1c was measured once every 3 month, self-monitoring blood glucose records were transferred to predicted HbA1c by prediction model every month.
Peking University People's Hospital
Beijing, Ch, China
RECRUITINGChange in measured HbA1c from baseline to 24 weeks
Time frame: 24 weeks
Change in measured HbA1c from baseline to 12 weeks
Time frame: 12 weeks
The percentages of participants with HbA1c less than 7.0% at 12 weeks
Time frame: 12 weeks
The percentages of participants with HbA1c less than 7.0% at 24 weeks
Time frame: 24 weeks
Change in weight from baseline to 24 weeks
Time frame: 24 weeks
The rate of severe hypoglycemic events and confirmed hypoglycemic events during the 24 weeks of the study
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.